companies eli-lilly-co 
Patently O
DECEMBER 21, 2020
Eli Lilly and Co v. Lilly’s US7772209 claims a particular treatment scheme for pemetrexed disodium that includes a pre-treatment with folic-acid to avoid the harsh side-effects. However, one original claim had limited the antifolate to “ALIMTA,” which is Lilly’s brand of Pemetrexed Disodium.
FDA Law Blog
APRIL 7, 2025
Karst will speak at a session, titled Hitting the Books: Examining Orange and Purple Book Delisting from a Patent Prosecutorial Perspective, along with co-presenters Kim Braslow (Senior Director, IP and Government Affairs, AstraZeneca) and Nicole Woods (Associate Vice President, Assistant General Patent Counsel, Eli Lilly and Company).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Intelligize Blog
JANUARY 9, 2024
Namely, rank-and-file workers decried the hefty pay packages doled out to C-suite occupants, while executives fired back with arguments that their performance and value to their companies justified their compensation. Importantly, the rule carves out space for a company-selected measure, which may include non-GAAP performance measures.
Law 360
JANUARY 8, 2024
Eli Lilly & Co. and Novartis could invest close to $3 billion in the development of artificial intelligence for drug discovery under two new agreements with a digital biology company owned by Google's parent company.
Law 360
JUNE 6, 2022
A former senior human resources employee at Eli Lilly & Co. claims she was fired after reporting manufacturing issues related to the pharmaceutical company's blockbuster diabetes treatment, including falsified batch data and missing regulatory protocols, according to a lawsuit filed Monday in New Jersey federal court.
Law 360
MAY 26, 2023
Insulin buyers asked a New Jersey federal judge Friday to greenlight a settlement with Eli Lilly & Co. that would resolve their class claims that the pharmaceutical company schemed to drive up insulin drug prices, in a deal the plaintiffs say could be worth more than $500 million over four years.
Law 360
OCTOBER 4, 2023
A former associate director of employee relations at Eli Lilly & Co. has reached a settlement with the pharmaceutical company on claims that she was fired in retaliation for reporting manufacturing issues with its cancer and diabetes treatments.
Expert insights. Personalized for you.
115 
Let's personalize your content